Comparison of the efficacy, safety and cost effectiveness of minocycline hydrochloride extended release versus minocycline in moderate to severe non-nodular facial acne vulgaris: A Randomised , parallel, open label, prospective study

Government Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects with inflammatory, non nodular moderate to severe facial acne vulgaris
•2.Subjects between 12-18 years of age, written assent will be taken.
•3.Subjects of either gender.
•4.Subjects willing to give written informed consent.

•1. Subjects with more than 2 nodules or cysts on the face,
•2. Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.),
•3. Female Subjects who are pregnant, nursing or planning a pregnancy during the study.
•4 Subjects with known or suspected allergy to one of the investigational products.
•5. Subjects with history of liver & kidney disorder.
•6. Subjects on anticoagulants, antacids, iron tablets..
•7. Subjects with history of autoimmune disorder.

发起方